I am sure you have read the fact that the majority of lupus patients are between 15 and 45. This is true, but lupus can develop at any age and even though 90% of patients are female it can affect men and children too. Doctors may dismiss lupus if the patient falls outside the 15 to 45 age range and this may lead to even further misdiagnosis.
ImmuPharma Plc (LON:IMM) is a pharmaceutical development company listed since 2006 on AIM of the London Stock Exchange, focusing on developing novel medicines with high sales potential in specialist markets with serious unmet need. The company is led by a commercially focused Board and management team with extensive experience.